Quanlin Y. An

Shanghai Key Laboratory Of Oncology Target Discovery And Antibody Drug Development
Zhongshan, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Novel cancer stem cell-targeted retinoid ZSH-512 impedes colorectal cancer progress via KDM3A-mediated epigenetic reprogramming.

Novel cancer stem cell-targeted retinoid ZSH-512 impedes colorectal cancer progress via KDM3A-mediated epigenetic reprogramming.

Journal: Innovation (Cambridge (Mass.))

Published: August 08, 2024

AcGlcAs: A Novel P53-Targeting Arsenical with Potent Cellular Uptake and Cancer Cell Selectivity.

AcGlcAs: A Novel P53-Targeting Arsenical with Potent Cellular Uptake and Cancer Cell Selectivity.

Journal: Journal of medicinal chemistry

Published: December 09, 2023

Discovery of MAO-B Inhibitor with Machine Learning, Topomer CoMFA, Molecular Docking and Multi-Spectroscopy Approaches.

Discovery of MAO-B Inhibitor with Machine Learning, Topomer CoMFA, Molecular Docking and Multi-Spectroscopy Approaches.

Journal: Biomolecules

Published: August 15, 2022

Synthetic Retinoid Kills Drug-Resistant Cancer Stem Cells via Inducing RARγ-Translocation-Mediated Tension Reduction and Chromatin Decondensation.

Synthetic Retinoid Kills Drug-Resistant Cancer Stem Cells via Inducing RARγ-Translocation-Mediated Tension Reduction and Chromatin Decondensation.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: May 29, 2022

Carbohydrate-based drugs launched during 2000-2021.

Carbohydrate-based drugs launched during 2000-2021.

Journal: Acta pharmaceutica Sinica. B

Published: March 02, 2022

Sulfarotene, a synthetic retinoid, overcomes stemness and sorafenib resistance of hepatocellular carcinoma via suppressing SOS2-RAS pathway.

Sulfarotene, a synthetic retinoid, overcomes stemness and sorafenib resistance of hepatocellular carcinoma via suppressing SOS2-RAS pathway.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 20, 2021

Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors.

Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors.

Journal: Innovation (Cambridge (Mass.))

Published: November 23, 2020

Towards the overcoming of anticancer drug resistance mediated by p53 mutations.

Towards the overcoming of anticancer drug resistance mediated by p53 mutations.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: October 22, 2019

Role of miR-221/222 in Tumor Development and the Underlying Mechanism.

Role of miR-221/222 in Tumor Development and the Underlying Mechanism.

Journal: Journal of oncology

Published: June 10, 2019

Peripheral small airway dysfunction differences between idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Peripheral small airway dysfunction differences between idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases

Published: December 08, 2018

Inhibition of cancer stem cell like cells by a synthetic retinoid.

Inhibition of cancer stem cell like cells by a synthetic retinoid.

Journal: Nature communications

Published: July 13, 2017

Showing 1-11 of 11

Last Updated: 09/26/2026